Whitebox Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-394,987
Closed -$70M 100
2020
Q1
$70M Buy
394,987
+56,000
+17% +$10.5M 3.55% 7
2019
Q4
$64.8M Hold
338,987
2.15% 7
2019
Q3
$57M Buy
338,987
+217,287
+179% +$35.4M 2.07% 9
2019
Q2
$20.4M Buy
+121,700
New +$16.9M 0.72% 24
2016
Q4
Sell
-48,699
Closed -$11.2M 93
2016
Q3
$11.2M Sell
48,699
-2,150
-4% -$525K 0.47% 35
2016
Q2
$11.8M Sell
50,849
-18,351
-27% -$4.23M 0.31% 38
2016
Q1
$18.5M Buy
69,200
+32,340
+88% +$9.26M 0.54% 27
2015
Q4
$11.5M Buy
+36,860
New +$11M 0.31% 43
2015
Q3
Sell
-6,358
Closed -$1.93M 405
2015
Q2
$1.93M Sell
6,358
-17,125
-73% -$5.11M 0.08% 206
2015
Q1
$6.99M Buy
23,483
+13,827
+143% +$3.94M 0.27% 78
2014
Q4
$2.49M Buy
+9,656
New +$2.41M 0.1% 166

Other funds holding AGN

Whitebox Advisors's AGN Position: Q2 2020 in Review

Whitebox Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 394,987 shares — an estimated $70M sold.

Whitebox Advisors first reported a position in AGN in Q4 2014 and held it in 11 quarters. The position peaked at $70M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Whitebox Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Whitebox Advisors sold 394,987 Allergan plc shares in Q2 2020, an estimated $70M.
  • Whitebox Advisors first reported a position in Allergan plc in Q4 2014 and held it in 11 quarters.
  • Whitebox Advisors's Allergan plc position peaked at $70M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Whitebox Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.